source
- Lilly Oncology President Jacob Van Naarden: A Music-Loving Dealmaker With Clear VisionJacob Van Naarden, who now leads Lilly Oncology and heads corporate business development, first gained attention on a Princeton University stage where he performed as a Broadway character during hi…
- BioNTech, DualityBio weigh future of HER2 ADC after modest Phase 3 breast cancer resultsBioNTech and DualityBio are assessing next steps for their HER2-targeted antibody-drug conjugate trastuzumab pamirtecan after a Phase 3 trial in breast cancer. The trial met its primary endpoint,…